@prefix ns1: <http://linked.opendata.cz/ontology/drug-encyclopedia/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://linked.opendata.cz/resource/ATC/P01BB51> a ns1:ATCConcept ;
    skos:notation "P01BB51" ;
    skos:prefLabel "Progvanil, kombinace"@cs,
        "Proguanil, combinations"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0173858> a ns1:Ingredient ;
    ns1:contraindicatedWith <http://linked.opendata.cz/resource/ndfrt/disease/N0000000999> ;
    ns1:description "A hydroxynaphthoquinone that has antimicrobial activity and is being used in antimalarial protocols.     "@en ;
    ns1:hasMechanismOfAction <http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000133> ;
    ns1:hasMedicinalProduct <http://linked.opendata.cz/resource/sukl/medicinal-product/MALARONE> ;
    ns1:hasPharmacologicalAction <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001329>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001469>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0007520> ;
    ns1:hasPhysiologicEffect <http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008707> ;
    ns1:hasPregnancyCategory <http://linked.opendata.cz/resource/fda-spl/pregnancy-category/C> ;
    ns1:mayPrevent <http://linked.opendata.cz/resource/ndfrt/disease/N0000003484> ;
    ns1:mayTreat <http://linked.opendata.cz/resource/ndfrt/disease/N0000002437>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000003484> ;
    ns1:title "Atovachon"@cs,
        "Atovaquone"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001329> a ns1:PharmacologicalAction ;
    ns1:description "Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.     "@en ;
    ns1:title "Antiinfekční látky"@cs,
        "Anti-infective agents"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001469> a ns1:PharmacologicalAction ;
    ns1:description "Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)     "@en ;
    ns1:title "Antimalarika"@cs,
        "Antimalarials"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0007520> a ns1:PharmacologicalAction ;
    ns1:description "Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.     "@en ;
    ns1:title "Enzymy - inhibitory"@cs,
        "Enzyme inhibitors"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000999> a ns1:DiseaseOrFinding ;
    ns1:description "Immunologically mediated adverse reactions to medicinal substances used legally or illegally.     "@en ;
    ns1:title "Léková alergie"@cs,
        "Drug hypersensitivity"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000002437> a ns1:DiseaseOrFinding ;
    ns1:description "A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis.     "@en ;
    ns1:title "Pneumocystová pneumonie"@cs,
        "Pneumonia, pneumocystis"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000003484> a ns1:DiseaseOrFinding ;
    ns1:description "Infections of the BRAIN caused by the protozoan TOXOPLASMA gondii that primarily arise in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES (see also AIDS-RELATED OPPORTUNISTIC INFECTIONS). The infection may involve the brain diffusely or form discrete abscesses. Clinical manifestations include SEIZURES, altered mentation, headache, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. (From Joynt, Clinical Neurology, 1998, Ch27, pp41-3)     "@en ;
    ns1:title "Mozková toxoplazmóza"@cs,
        "Toxoplasmosis, cerebral"@en .

<http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000133> a ns1:MechanismOfAction ;
    ns1:title "Enzyme Inhibitors"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008707> a ns1:PhysiologicEffect ;
    ns1:title "Decreased Metabolic Rate"@en .

<http://linked.opendata.cz/resource/sukl/medicinal-product/MALARONE> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/P01BB51> ;
    ns1:title "MALARONE"@cs .


